AP31969

DRUG4 trials

Sponsors

Acesion Pharma ApS, Acesion Pharma

Conditions

Atrial Fibrillation (AF)Atrial fibrillationHealthy ParticipantsHealthy Volunteers

Phase 1

Single Ascending Dose, Multiple Ascending Dose, Food Effect Study With AP31969

CompletedNCT06066099

Acesion PharmaHealthy Volunteers

Start: 2023-10-04End: 2025-03-14Updated: 2025-07-14

Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole

CompletedNCT07449390

Acesion PharmaHealthy Participants

Start: 2026-04-01End: 2026-05-16Updated: 2026-05-22

Phase 2

Clinical Randomised Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.

RecruitingCTIS2025-521377-14-00

Acesion Pharma ApSAtrial fibrillation

Start: 2025-10-06Target: 180Updated: 2025-11-06

Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

RecruitingNCT07267949

Acesion PharmaAtrial Fibrillation (AF)

Start: 2025-10-22End: 2026-12-01Target: 200Updated: 2026-06-12